Correlation Between Alx Oncology and ADC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alx Oncology and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alx Oncology Holdings and ADC Therapeutics SA, you can compare the effects of market volatilities on Alx Oncology and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and ADC Therapeutics.
Diversification Opportunities for Alx Oncology and ADC Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Alx and ADC is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of Alx Oncology i.e., Alx Oncology and ADC Therapeutics go up and down completely randomly.
Pair Corralation between Alx Oncology and ADC Therapeutics
Given the investment horizon of 90 days Alx Oncology Holdings is expected to generate 0.39 times more return on investment than ADC Therapeutics. However, Alx Oncology Holdings is 2.58 times less risky than ADC Therapeutics. It trades about 0.07 of its potential returns per unit of risk. ADC Therapeutics SA is currently generating about -0.03 per unit of risk. If you would invest 134.00 in Alx Oncology Holdings on September 13, 2024 and sell it today you would earn a total of 8.00 from holding Alx Oncology Holdings or generate 5.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alx Oncology Holdings vs. ADC Therapeutics SA
Performance |
| Timeline |
| Alx Oncology Holdings |
| ADC Therapeutics |
Alx Oncology and ADC Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alx Oncology and ADC Therapeutics
The main advantage of trading using opposite Alx Oncology and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.| Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
| ADC Therapeutics vs. Passage Bio | ADC Therapeutics vs. Black Diamond Therapeutics | ADC Therapeutics vs. Alector | ADC Therapeutics vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |